IP Library Granted Patent US 8,034,796
Granted Patent B2
US 8,034,796 · App. 11/547,898 · Granted Oct 11, 2011

Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods

Assignee: The University of Georgia Research Foundation, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,034,796
App. No.
11/547,898
Granted
Oct 11, 2011
Kind
B2
Abstract

Mutual prodrugs of glucosamine, and derivatives and analogs of glucosamine and an anti-inflammatory agent, compositions thereof, and methods for, e.g., treating disorders and conditions by administration of the compositions are provided. Topical compositions of glucosamine, and derivatives and analogs of glucosamine are also provided.

Claims (13)

1. A pharmaceutical composition comprising a therapeutically effective amount of a compound having formula II:

wherein R 1 , R 2 , R 3 , R 4 and R 5 are each independently H or an organic group; and a pharmaceutically acceptable carrier;

wherein the composition is formulated for transdermal application and the permeation coefficient k p of the compound of formula II in shed snake skin is at least about 2.5×10 −4 cm/h.

2. The pharmaceutical composition of claim 1 further comprising at least one anti-inflammatory agent.

3. The pharmaceutical composition of claim 1 wherein the carrier is selected from the group consisting of an ointment, a gel, a cream, a solution, a lotion, a suspension, a microemulsion, an emulsion, a liposome, or a transdermal patch.

4. A pharmaceutical composition comprising a therapeutically effective amount of a compound having formula II:

wherein R 1 , R 2 , R 3 and R 4 are each H, and R 5 is an acetyl group; and

a pharmaceutically acceptable carrier; wherein the composition is formulated for transdermal application and the permeation coefficient k p of the compound of formula II in shed snake skin is at least about 2.5×10 −4 cm/h.

5. The pharmaceutical composition of claim 4 further comprising an anti-inflammatory agent.

6. The pharmaceutical composition of claim 1 further comprising one or more additional components selected from the group consisting of an antimicrobial agent, a gelling agent, an emulsifying agent, a stiffening agent, a skin healing agent, an emollient, a surfactant, a solvent, a lubricant, a wax, a humectant, a skin penetration enhancer, an antioxidant, and combinations thereof.

7. The pharmaceutical composition of claim 6 wherein the skin penetration enhancer is selected from the group consisting of dimethyl sulfoxide, ethanol, isopropyl palmitate, isopropyl myristate, cetyl alcohol, stearyl alcohol, cetostearyl alcohol, polyethylene glycol, urea, dimethyl acetamide, sodium lauryl sulfate, Spans, Tweens, terpenes, azone, acetone, oleic acid, and combinations thereof.

8. The pharmaceutical composition of claim 4 further comprising one or more additional components selected from the group consisting of an antimicrobial agent, a gelling agent, an emulsifying agent, a stiffening agent, a skin healing agent, an emollient, a surfactant, a solvent, a lubricant, a wax, a humectant, a skin penetration enhancer, an antioxidant, and combinations thereof.

9. The pharmaceutical composition of claim 8 wherein the skin penetration enhancer is selected from the group consisting of dimethyl sulfoxide, ethanol, isopropyl palmitate, isopropyl myristate, cetyl alcohol, stearyl alcohol, cetostearyl alcohol, polyethylene glycol, urea, dimethyl acetamide, sodium lauryl sulfate, Spans, Tweens, terpenes, azone, acetone, oleic acid, and combinations thereof.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 25, 2018
From: UNIVERSITY OF GEORGIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045148/0077 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2006
From: CAPOMACCHIA, ANTHONY C.; GARNER, SOLOMON T., JR.; BEACH, J. WARREN
To: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC., THE
Reel/Frame 018434/0556 →
Continuity (2)
Provisional Application 60560128 · Apr 7, 2004
Related Publication 20080020997A1 · Jan 24, 2008